ArticleFrontiers in oncology2022

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma.

Yunchao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.